Massachusetts medical device maker Haemonetics (NYSE:HAE) this week released its 3rd-quarter earnings report, posting a major boost in profits that the company attributed to "productivity programs yielding cost efficiencies."
Blood Management
GPOs: Haemonetics inks supply deal with HemeXcel
Haemonetics (NYSE:HAE) signed a 2-year exclusive supply deal with HemeXcel Purchasing Alliance LLC, providing blood collection devices to group purchasing organization HemeXcel’s 5 blood centers.
Brazil investigates BD in anti-dumping probe
Becton Dickinson & Co. (NYSE:BDX) said a Brazilian agency today began an anti-dumping probe that’s looking into sales in Brazil of its vacuum tubes used to collect blood.
Fenwal lands 510(k) clearance for Alyx blood collection software
Fenwal Inc. said it landed 510(k) clearance from the FDA for a new version of software for its Alyx blood collection system.
Terumo acquires Turkish blood bank distributor
Terumo BCT, a subsidiary of Terumo Corp. (TYO:4543), said it acquired its onetime blood products distributor GADA Turkey for an undisclosed amount.
GADA Turkey, a subsidiary of the GADA Group Holding, was a Terumo BCT distributor to blood banks and hospitals in Turkey since 2009.
Listen to Haemonetics Q2 2014 earnings call
Haemonetics’ Q2 profits surge, lowers sales outlook
Haemonetics (NYSE:HAE) said its fiscal 2nd-quarter profits surged more than 150%, but lowered its sales outlook for the rest of fiscal 2014 on its expectation that blood transfusion rates will continue to slow down.
Baxter can question FDA official in plasma therapy price-fixing case
Study: GlySure’s continuous glucose monitoring looks good in the ICU
Strengthening newborns’ immune systems: A secret in the plasma
The immunosuppressant effect in newborns’ blood comes not from blood cells themselves, but from the plasma that surrounds them (smaller.pathological.ca/Flickr)
By Sarah Lewin
There’s something different about newborns’ blood. In babies less than 28 days of age, the immune system still hibernates – making newborns more susceptible to life-threatening infections and less responsive to many vaccines.